series-a
Stage
1
Investors
About
RayThera develops small molecule therapies targeting critical unmet medical needs in immunology, leveraging drug discovery expertise to accelerate the development of transformative treatments.
Explore RayThera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.